🇺🇸 phosphomycin in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Condition Aggravated — 2 reports (18.18%)
  2. Anorexia — 1 report (9.09%)
  3. Arthritis — 1 report (9.09%)
  4. Atrioventricular Block Complete — 1 report (9.09%)
  5. Blood Lactic Acid Increased — 1 report (9.09%)
  6. Blood Potassium Decreased — 1 report (9.09%)
  7. Bradycardia — 1 report (9.09%)
  8. Brain Herniation — 1 report (9.09%)
  9. Brain Oedema — 1 report (9.09%)
  10. Hypocapnia — 1 report (9.09%)

Source database →

Other Other approved in United States

Frequently asked questions

Is phosphomycin approved in United States?

phosphomycin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for phosphomycin in United States?

Ain Shams University is the originator. The local marketing authorisation holder may differ — check the official source linked above.